Business
Bexil Corporation Announces Potential Launch of Modified Dutch Auction and Preliminary Price Range
Bexil Corporation Announces Potential Launch of Modified Dutch Auction and Preliminary Price Range.
About this update from Bexil Corp.
[{"type":"text","content":"March 18, 2024 – Bexil Corporation (Stock Symbol: BXLC) (“Bexil” or the “Company”) today announced that it anticipates that it will launch a modified Dutch auction for a cash purchase price of not greater than $38.00 nor less than $35.00 per share in the coming weeks. A subsequent press release will be issued upon the potential launch of the modified Dutch auction. All of the foregoing is subject to change, including, without limitation, the preliminary price range of the cash purchase price.THIS PRELIMINARY ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY. THIS ANNOUNCEMENT IS NOT AN OFFER TO PURCHASE OR A SOLICITATION OF AN OFFER TO PURCHASE ANY COMPANY SHARES. ANY SUCH TENDER OFFER WILL BE MADE SOLELY PURSUANT TO AN OFFER TO PURCHASE AND RELATED DOCUMENTS. ANY SUCH THE TENDER OFFER WILL NOT BE MADE IN ANY JURISDICTION IN WHICH THE MAKING OR ACCEPTANCE THEREOF WOULD NOT BE IN COMPLIANCE WITH THE SECURITIES, BLUE SKY OR OTHER LAWS OF SUCH JURISDICTION.About Bexil CorporationThe objective of Bexil, a holding company, is to increase book value per share over time for the benefit of its stockholders. The Company is primarily engaged through a wholly owned subsidiary, Bexil Advisers LLC, in investment management. Bexil Advisers is a registered investment adviser and the investment manager to Bexil Investment Trust, a closed end fund (Stock Symbol: BXSY) (NAV Symbol: XBXIX). To learn more about Bexil please visit www.Bexil.com.Safe Harbor NoteThis release may contain certain “forward looking statements” within the meaning of federal securities laws including, but not limited to the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Bexil, which may cause the Company’s actual results to be materially different from those expressed or implied by such statements. The Company may also make additional forward looking statements from time to time. All such subsequent forward looking statements, whether written or oral, by the Company or on its behalf, are also expressly qualified by these cautionary statements. Investors should carefully consider the risks, uncertainties, and other factors, together with the information included in the Company’s Annual Report, at https://www.bexil.com/communications/cautionary-language...